Showing results (411-420 of 424) with videos related to
Sort By:
Pageof 43
Journal of Pharmaceutical Sciences|April 12, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approachRagini Vuppugalla, Punit Marathe, Handan He, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient-Derived Xenograft ModelsAlwin G Schuller, Evan R Barry, Rhys D O Jones, et al.Journal of Pharmaceutical Sciences|May 5, 2011
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approachPatrick Poulin, Rhys D O Jones, Hannah M Jones, et al.Journal of Medicinal Chemistry|September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal TumorsJason G Kettle, Rana Anjum, Evan Barry, et al.Molecular Cancer Therapeutics|December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activityRobert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.Physiological Genomics|January 5, 2002
A compendium of gene expression in normal human tissuesL L Hsiao, F Dangond, T Yoshida, et al.Molecular Cancer Therapeutics|July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivoSarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.Bioorganic & Medicinal Chemistry Letters|March 8, 2013
Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancerRobert H Bradbury, David G Acton, Nicola L Broadbent, et al.Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic lossMaria Talantova, Sara Sanz-Blasco, Xiaofei Zhang, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
An Expanded Registry of Candidate cis-Regulatory Elements for Studying Transcriptional RegulationJill E Moore, Henry E Pratt, Kaili Fan, et al.Pageof 43